The predicted change of expression is in agreement with Pancan data on breast cancer patients that show the alternative allele of this variant to be associated with higher expression levels of CHPT1 gene (source: PancanQTL53, beta = 0.17; see Supplementary Fig. 7). Here, CHPT1 is linked to breast cancer.